BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Phenytoin readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Phenytoin\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07590375-4393@assetmemo.bio
DTSTAMP:20261121T005635Z
DTSTART;VALUE=DATE:20270901
DTEND;VALUE=DATE:20270902
SUMMARY:Phenytoin: Phase 2/3 readout est. (NCT07590375)
DESCRIPTION:Phenytoin\, phase 2/3.\nStudy: Topical Phenytoin for Management
  of Gingival Recession\nEstimated primary completion: 1 September 2027. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/phenytoin#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT07590375
URL:https://assetmemo.bio/drug/phenytoin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
